Northwire Canada EditionSunday, August 16, 2026
Northwire
ERD 6.16 −1.4% NFG 2.37 +2.2% CLM 0.060 +0.0% GEMG 1.64 +0.0% STGO 1.56 +2.6% WEX 0.580 −3.3% NOBL 0.120 +9.1% LGO 1.00 −3.9% SSE 0.095 +0.0% AAZ 0.040 +0.0% MNRG 0.095 +11.8% RME 0.260 +30.0% NUAG 9.48 +1.3% KRN 0.300 +11.1% EON 0.020 −nan% EMO 0.420 −1.2% ERD 6.16 −1.4% NFG 2.37 +2.2% CLM 0.060 +0.0% GEMG 1.64 +0.0% STGO 1.56 +2.6% WEX 0.580 −3.3% NOBL 0.120 +9.1% LGO 1.00 −3.9% SSE 0.095 +0.0% AAZ 0.040 +0.0% MNRG 0.095 +11.8% RME 0.260 +30.0% NUAG 9.48 +1.3% KRN 0.300 +11.1% EON 0.020 −nan% EMO 0.420 −1.2%
Financings

Canalaska arranges $15-million private placement

CVV · Price

Executive Summary

  • Canalaska Uranium Ltd. announced a best‑efforts private placement to raise up to C$15 million by issuing up to 9,757,500 common shares (C$1.50 per non‑flow‑through share and C$1.65 per charity flow‑through share).
  • Proceeds will be used for Canadian exploration expenses, including qualifying expenditures on the West McArthur project and other Saskatchewan projects, with eligible Saskatchewan subscribers receiving tax‑credit‑eligible flow‑through mining expenditures.
  • The offering is expected to close on or about October 30, 2025, subject to customary conditions and TSX Venture Exchange approval; agents will receive a 6.0% cash commission on gross proceeds.

Key Details

  • Securities Offered: Up to 9,757,500 common shares comprising:
  • Charity flow‑through (NFT) shares at C$1.50 each.
  • Charity flow‑through (SFT) shares for eligible Saskatchewan subscribers at C$1.65 each.
  • Gross Proceeds Target: Up to C$15 million.
  • Use of Proceeds:
  • Canadian exploration expenses that qualify as flow‑through critical mineral mining expenditures.
  • Eligible Saskatchewan flow‑through mining expenditures qualifying for the Saskatchewan Mineral Exploration Tax Credit, to be renounced by Dec 31, 2025 (tax credit claimable by Dec 31, 2026).
  • Projects Funded: Primarily the West McArthur uranium project and other exploration projects in Saskatchewan.
  • Closing Date: Expected on or about 30 Oct 2025, or earlier/later as agreed.
  • Commission to Agents: Cash commission equal to 6.0% of gross proceeds.
  • Exemption Basis: Offered under the Listed Issuer Financing Exemption (LIFE) pursuant to NI 45‑106 and CSA Coordinated Blanket Order 45‑935; no resale restrictions in Canada.
  • Bookrunner: Desjardins Capital Markets, acting as sole bookrunner for a syndicate of agents.

Notable Quotes

(No direct quotes were provided in the release.)

Read the original news release →

More from Canalaska Uranium Ltd.